Leo Cancer Care
12 known investors
Find your way into Leo Cancer Care
30 people in our graph share verified history with the Leo Cancer Care team — schools, employers, funds. One of them is your warm intro.
Leo Cancer Care develops upright radiotherapy and particle therapy solutions that integrate CT imaging with patient positioning systems. The company serves oncology clinics and cancer treatment facilities seeking to improve treatment precision and patient comfort through innovative imaging and adaptive therapy approaches.
Founders & leadership

Investors · 12
Also in the syndicate · 7
Funding
SEC filings, press & company announcements$40M disclosed across 1 of 3 rounds · 2024–2026
- Undisclosed amountSeries DJul 2026
Yu Galaxy (lead), Eventide Asset Management
Source ↗ - $40MraisedSep 2025 · 3 sources
Catalio Capital Management (lead)
Source ↗ - Undisclosed amountSeries CJun 2024
Aviko Radiopharmaceuticals, Cone Health, EDBI, Macmillan Cancer Support, McLaren Healthcare Corporation, Wisconsin Alumni Research Foundation
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Leo Cancer Care do?
- Leo Cancer Care develops upright radiotherapy and particle therapy solutions that integrate CT imaging with patient positioning systems. The company serves oncology clinics and cancer treatment facilities seeking to improve treatment precision and patient comfort through innovative imaging and adaptive therapy approaches.
- Who founded Leo Cancer Care?
- Leo Cancer Care was founded by Stephen Towe.
- Who are Leo Cancer Care's investors?
- Leo Cancer Care's investors include Catalio Capital Management, LP, Yu Galaxy, Catalio Capital Management, Mana Ventures, Serra Ventures.
- How much funding has Leo Cancer Care raised?
- Leo Cancer Care has disclosed $40M raised across 1 of its 3 known rounds.


